Using
new treatments to improve the success of Organ Transplants these
companies: BioTransplants (BTRN), MedImmune (MEDI), Protein Design
Labs (PDLI) and SangStat Medical (SANG) are leading the market
towards new treatments that are making Organ Transplants more
successful by making the chances of Organ Rejection slimmer than
ever. You might be interested in our broader Biotechnology
and Pharmaceutical
Lists.
|
The
Organ Transplant Stock List
ABT PDLI
ABT
through PDLI
Let me see a chart at Big
Charts
Let me search for more news
SEARCH
YAHOO NEWS